Vayet Pharma S.A. (production of lyophilizate in full cycle; quality control of solvent (except "Piston friction force" test); packaging of solvent into a set; quality control, storage, packaging and batch release of the set; responsible for batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: lyophilisate for solution for injection
Active substance Dosage nonacog alfa 250 IU ATC: B02BD04
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: lyophilisate for solution for injection
Active substance Dosage nonacog alfa 500 IU ATC: B02BD04
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: lyophilisate for solution for injection
Active substance Dosage nonacog alfa 1000 IU ATC: B02BD04
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: lyophilisate for solution for injection
Active substance Dosage nonacog alfa 2000 IU ATC: B02BD04
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: lyophilisate for solution for injection
Active substance Dosage nonacog alfa 3000 IU ATC: B02BD04